Lifeforce Capital invests in digital health companies enabling new care delivery models or more efficient therapeutic development.
Business Model:
Revenue: $0
Employees: 0-0
Address:
City:
State:
Zip:
Country:
Lifeforce Capital invests in digital health companies enabling new care delivery models or more efficient therapeutic development. Lifeforce Capital is headquartered in San Francisco, California.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
8/2015 | Included Health (previously Grand Rounds Health and Doctor On Demand) | Series C | 55M |
9/2021 | Fauna Bio | Seed Round | 0 |
5/2022 | Character Biosciences | Series A | 0 |
4/2016 | Second Genome | Series B | 51M |
2/2018 | Senti Biosciences | Series A | 53M |
1/2020 | Vivante Health | Series A | 5.8M |
5/2022 | MindRight Health | Seed Round | 0 |
12/2021 | Mythic Therapeutics | Series B | 0 |
10/2020 | Vineti | Series C | 33M |
2/2020 | Vineti | Series C | 35M |
1/2022 | PostEra | Series A | 0 |
4/2017 | Circle Pharma | Series A | 0 |
1/2022 | 64x Bio | Series A | 0 |
6/2021 | Sempre Health | Series B | 15M |
9/2020 | Sonoma Pharmaceuticals | Post-IPO Equity | 70M |
1/2016 | Advantia Health | Venture Round | - |
9/2020 | Sonoma BioTherapeutics | Series A | 0 |
6/2015 | Aspire Health | Series C | 15M |
9/2017 | Notable Labs | Series A | 14.8M |
12/2018 | Vivante Health | Series A | 6M |
3/2022 | Vivante Health | Series A | 0 |
1/2021 | People Science | Seed Round | 3.2M |
11/2017 | Floreo | Seed Round | 2.1M |
2/2014 | HeartFlow | Series C | 104.7M |
9/2018 | Cricket Health | Series A | 0 |
5/2017 | Clover Health | Series D | 130M |
12/2016 | Circle Pharma | Series A | 0 |
12/2021 | Verge Genomics | Series B | 98M |
7/2019 | Notable Labs | Series B | 0 |
6/2021 | Enveda Biosciences | Series A | 51M |
8/2021 | Sonoma BioTherapeutics | Series B | 0 |
5/2022 | Aspen Neuroscience | Series B | 0 |
1/2021 | Senti Biosciences | Series B | 105M |
10/2022 | Ochre Bio | Series A | 0 |
7/2018 | Verge Genomics | Series A | 0 |
6/2017 | Vineti | Series A | 13.8M |
4/2014 | One Medical | Private Equity Round | 40M |
10/2015 | Verge Genomics | Seed Round | 4M |
1/2021 | Sitka | Series A | 0 |
3/2020 | Circle Pharma | Series B | 0 |
11/2020 | Transition Bio | Seed Round | - |
6/2020 | TARA Biosystems | Series A | 0 |
9/2017 | Notable Labs | Series B | 14.8M |
1/2014 | Eko | Seed Round | 800k |
4/2018 | Sitka | Seed Round | 3.2M |
2/2022 | Synapticure | Seed Round | 0 |
12/2015 | dr.consulta | Series B | - |
7/2021 | Bayesian Health | Venture Round | 0 |
6/2022 | Transition Bio | Series A | 0 |
8/2018 | Sempre Health | Series A | 8M |
4/2020 | Character Biosciences | Seed Round | 6M |
4/2018 | Vineti | Series B | 33.5M |
1/2021 | Wren Therapeutics | Venture Round | 17M |
1/2019 | Wren Therapeutics | Series A | 23.3M |
6/2022 | Transition Bio | Series A | 0 |
5/2022 | MindRight Health | Seed Round | 0 |
5/2022 | Character Biosciences | Series A | 0 |
5/2022 | Aspen Neuroscience | Series B | 0 |
3/2022 | Vivante Health | Series A | 0 |
2/2022 | Synapticure | Seed Round | 0 |
1/2022 | 64x Bio | Series A | 0 |
1/2022 | PostEra | Series A | 0 |
12/2021 | Verge Genomics | Series B | 0 |
12/2021 | Mythic Therapeutics | Series B | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|